Mauro Cataldi

Associate Professor in Pharmacology

University of Naples Federico II

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Mauro Cataldi is an Associate Professor in Pharmacology at the University of Naples Federico II, Italy. His recent research focuses on the pharmacological implications of cholesterol modulation in skeletal muscles and the pharmacomicrobiomics of immunosuppressant drugs. He has also contributed to studies on drug interactions in geriatric patients and pharmacovigilance in the context of new therapies, specifically regarding the safety of Axicabtagene Ciloleucel.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Giuseppe Rengo

Associate Professor of Medicine

Università degli Studi di Napoli Federico II

ITALY

View details

Maria Serena Lonardo

Fatebenefratelli Hospital

ITALY

View details

Claudia Vetrani

Associate Professor in Human Nutrition

Università Telematica Pegaso

ITALY

View details

Maurizio Taglialatela

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mauro Cataldi

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Evidence That Skeletal Muscles Modulate HDL-Cholesterol in Metabolic Healthy Young Adults

Identification of Drugs Acting as Perpetrators in Common Drug Interactions in a Cohort of Geriatric Patients from Southern Italy and Analysis of the Gene Polymorphisms That Affect Their Interacting Potential

A Pharmacovigilance Study on the Safety of Axicabtagene Ciloleucel Based on Spontaneous Reports from the EudraVigilance Database

COMBINED USE OF HANDGRIP STRENGTH AND HEMOGLOBIN AS MARKERS OF UNDERNUTRITION IN PATIENTS WITH STAGE 3-5 CHRONIC KIDNEY DISEASE

Pharmacomicrobiomics of Classical Immunosuppressant Drugs: A Systematic Review

Could Alcohol Abuse and Dependence on Junk Foods Inducing Obesity and/or Illicit Drug Use Represent Danger to Liver in Young People with Altered Psychological/Relational Spheres or Emotional Problems?

From the Ketogenic Diet to the Mediterranean Diet: The Potential Dietary Therapy in Patients with Obesity after CoVID-19 Infection (Post CoVID Syndrome)

Neurological risks and benefits of cytokine‐based treatments in coronavirus disease 2019: from preclinical to clinical evidence

Steatosis, Steatohepatitis and Cancer Immunotherapy: An Intricate Story

Findings from Studies Are Congruent with Obesity Having a Viral Origin, but What about Obesity-Related NAFLD?

Neurobiology of coronaviruses: Potential relevance for COVID-19

Collaborators (4)

Giuseppe Rengo

Maria Serena Lonardo

Claudia Vetrani

Maurizio Taglialatela

Make your next move.